co legal problems done. They have 9 million in the bank and can borrow still from FIRST lender 13 million more, and second lender another 26 million. Also the FDA has changed language so fully expect free funding from the NIH and others. The orphan drug status will probably let them skip phase 2 and jump into a phase three large trial. A debt free ACTC now means a partnership with big pharma. And then a reverse split. Lets hope the reverse comes soon so all the nonsense can be behind us.